Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Contact Lenses | 25 | 2023 | 145 | 7.630 |
Why?
|
Corneal Diseases | 20 | 2023 | 615 | 3.800 |
Why?
|
Contact Lenses, Hydrophilic | 7 | 2023 | 64 | 3.240 |
Why?
|
Sclera | 13 | 2023 | 200 | 2.630 |
Why?
|
Keratoconus | 7 | 2022 | 121 | 2.350 |
Why?
|
Prostheses and Implants | 13 | 2019 | 1385 | 2.030 |
Why?
|
Refractive Errors | 5 | 2022 | 142 | 1.880 |
Why?
|
Prosthesis Fitting | 10 | 2023 | 74 | 1.840 |
Why?
|
Dry Eye Syndromes | 9 | 2023 | 382 | 1.590 |
Why?
|
Refractive Surgical Procedures | 3 | 2022 | 25 | 1.550 |
Why?
|
Ophthalmology | 10 | 2022 | 506 | 1.530 |
Why?
|
Visual Acuity | 22 | 2022 | 2520 | 1.430 |
Why?
|
Stevens-Johnson Syndrome | 6 | 2021 | 277 | 1.320 |
Why?
|
Corneal Neovascularization | 4 | 2018 | 188 | 1.300 |
Why?
|
Cornea | 12 | 2023 | 1497 | 1.260 |
Why?
|
Anterior Eye Segment | 3 | 2019 | 153 | 1.150 |
Why?
|
Eye, Artificial | 3 | 2015 | 18 | 1.060 |
Why?
|
Acanthamoeba Keratitis | 2 | 2022 | 17 | 1.040 |
Why?
|
Ecosystem | 4 | 2022 | 471 | 1.040 |
Why?
|
Asthenopia | 1 | 2023 | 12 | 0.930 |
Why?
|
Orthokeratologic Procedures | 2 | 2021 | 6 | 0.870 |
Why?
|
Corneal Ulcer | 2 | 2021 | 169 | 0.850 |
Why?
|
Contact Lenses, Extended-Wear | 4 | 2022 | 12 | 0.830 |
Why?
|
Lenses, Intraocular | 3 | 2019 | 142 | 0.770 |
Why?
|
Lens, Crystalline | 1 | 2023 | 388 | 0.760 |
Why?
|
Corneal Dystrophies, Hereditary | 2 | 2021 | 80 | 0.760 |
Why?
|
Knowledge | 1 | 2022 | 179 | 0.750 |
Why?
|
Computers | 1 | 2023 | 611 | 0.750 |
Why?
|
Endothelium, Corneal | 3 | 2019 | 147 | 0.700 |
Why?
|
Ulcer | 1 | 2020 | 209 | 0.680 |
Why?
|
Keratitis | 5 | 2022 | 268 | 0.670 |
Why?
|
Light | 2 | 2023 | 1374 | 0.670 |
Why?
|
Tears | 3 | 2019 | 252 | 0.650 |
Why?
|
Keratomileusis, Laser In Situ | 2 | 2016 | 88 | 0.650 |
Why?
|
Dilatation, Pathologic | 6 | 2022 | 520 | 0.640 |
Why?
|
Lacrimal Apparatus | 2 | 2023 | 224 | 0.630 |
Why?
|
Astigmatism | 3 | 2015 | 70 | 0.620 |
Why?
|
Vision Disorders | 5 | 2022 | 1057 | 0.560 |
Why?
|
Microscopy, Confocal | 5 | 2021 | 1969 | 0.530 |
Why?
|
Prosthesis Design | 9 | 2019 | 2110 | 0.520 |
Why?
|
Uveitis | 1 | 2019 | 375 | 0.520 |
Why?
|
Glaucoma Drainage Implants | 2 | 2017 | 116 | 0.470 |
Why?
|
Tomography, Optical Coherence | 2 | 2019 | 2637 | 0.460 |
Why?
|
Angiogenesis Inhibitors | 4 | 2018 | 2038 | 0.450 |
Why?
|
Sjogren's Syndrome | 1 | 2015 | 229 | 0.440 |
Why?
|
Corneal Topography | 5 | 2021 | 71 | 0.440 |
Why?
|
Keratoconjunctivitis Sicca | 2 | 2011 | 27 | 0.420 |
Why?
|
Academies and Institutes | 7 | 2021 | 317 | 0.380 |
Why?
|
Graft vs Host Disease | 5 | 2016 | 2951 | 0.370 |
Why?
|
Ophthalmic Nerve | 2 | 2016 | 43 | 0.370 |
Why?
|
Eye Infections, Fungal | 2 | 2021 | 110 | 0.350 |
Why?
|
Alkylating Agents | 4 | 2013 | 139 | 0.350 |
Why?
|
Forecasting | 1 | 2018 | 2948 | 0.350 |
Why?
|
Mitomycin | 4 | 2013 | 259 | 0.340 |
Why?
|
Pterygium | 3 | 2013 | 26 | 0.340 |
Why?
|
Refraction, Ocular | 4 | 2021 | 181 | 0.340 |
Why?
|
Lens Capsule, Crystalline | 2 | 2006 | 43 | 0.330 |
Why?
|
Conjunctival Diseases | 3 | 2009 | 121 | 0.330 |
Why?
|
Drug Delivery Systems | 2 | 2018 | 2217 | 0.330 |
Why?
|
Trabeculectomy | 1 | 2010 | 162 | 0.330 |
Why?
|
Keratoconjunctivitis | 2 | 2021 | 53 | 0.330 |
Why?
|
Cranial Nerve Diseases | 1 | 2009 | 112 | 0.320 |
Why?
|
Eye Infections, Bacterial | 2 | 2021 | 235 | 0.320 |
Why?
|
Amnion | 3 | 2013 | 208 | 0.300 |
Why?
|
Disease Management | 2 | 2015 | 2450 | 0.300 |
Why?
|
Postoperative Complications | 5 | 2017 | 15244 | 0.290 |
Why?
|
Eye Infections | 2 | 2018 | 64 | 0.290 |
Why?
|
Humans | 71 | 2023 | 742088 | 0.270 |
Why?
|
Ophthalmologic Surgical Procedures | 3 | 2013 | 349 | 0.270 |
Why?
|
Glaucoma | 2 | 2017 | 1152 | 0.260 |
Why?
|
Conjunctiva | 3 | 2013 | 493 | 0.260 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18006 | 0.240 |
Why?
|
Technology Assessment, Biomedical | 5 | 2011 | 307 | 0.230 |
Why?
|
Optometry | 2 | 2021 | 30 | 0.230 |
Why?
|
Coloring Agents | 1 | 2006 | 565 | 0.230 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3502 | 0.220 |
Why?
|
Eye Pain | 1 | 2023 | 47 | 0.220 |
Why?
|
Neuralgia | 1 | 2009 | 568 | 0.210 |
Why?
|
Rodentia | 1 | 2023 | 262 | 0.200 |
Why?
|
Cataract Extraction | 1 | 2006 | 482 | 0.200 |
Why?
|
Corynebacterium Infections | 1 | 2021 | 27 | 0.200 |
Why?
|
Encephalitozoon | 1 | 2021 | 5 | 0.200 |
Why?
|
Eye Infections, Parasitic | 1 | 2021 | 24 | 0.200 |
Why?
|
Microsporidiosis | 1 | 2021 | 23 | 0.190 |
Why?
|
Retrospective Studies | 14 | 2022 | 77098 | 0.190 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7276 | 0.190 |
Why?
|
Corneal Perforation | 1 | 2019 | 32 | 0.170 |
Why?
|
Epithelium, Corneal | 3 | 2013 | 241 | 0.170 |
Why?
|
Prosthesis Implantation | 2 | 2016 | 641 | 0.160 |
Why?
|
Siblings | 1 | 2023 | 854 | 0.160 |
Why?
|
Sickness Impact Profile | 3 | 2014 | 304 | 0.150 |
Why?
|
Sex Distribution | 1 | 2022 | 2295 | 0.150 |
Why?
|
Adult | 22 | 2021 | 213712 | 0.140 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 1 | 2017 | 61 | 0.140 |
Why?
|
Middle Aged | 23 | 2021 | 213127 | 0.140 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2017 | 66 | 0.140 |
Why?
|
Corneal Transplantation | 2 | 2011 | 368 | 0.140 |
Why?
|
Cross-Linking Reagents | 1 | 2019 | 694 | 0.140 |
Why?
|
Phacoemulsification | 1 | 2017 | 149 | 0.130 |
Why?
|
Eye | 1 | 2019 | 728 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2009 | 9274 | 0.130 |
Why?
|
Foreign-Body Migration | 1 | 2017 | 221 | 0.120 |
Why?
|
Male | 25 | 2023 | 349538 | 0.120 |
Why?
|
Trigeminal Neuralgia | 1 | 2015 | 113 | 0.120 |
Why?
|
Microbial Sensitivity Tests | 2 | 2021 | 1871 | 0.120 |
Why?
|
Skull Base Neoplasms | 1 | 2017 | 284 | 0.120 |
Why?
|
Osmolar Concentration | 1 | 2015 | 683 | 0.120 |
Why?
|
Disinfection | 1 | 2015 | 191 | 0.120 |
Why?
|
Female | 24 | 2021 | 379592 | 0.110 |
Why?
|
Photochemotherapy | 1 | 2019 | 804 | 0.110 |
Why?
|
Vision, Ocular | 1 | 2016 | 463 | 0.110 |
Why?
|
Risk-Taking | 1 | 2018 | 986 | 0.110 |
Why?
|
Aged | 12 | 2021 | 162944 | 0.110 |
Why?
|
Hyperalgesia | 1 | 2016 | 502 | 0.110 |
Why?
|
Young Adult | 5 | 2018 | 56350 | 0.100 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39004 | 0.090 |
Why?
|
Keratoplasty, Penetrating | 1 | 2011 | 154 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2019 | 2556 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 867 | 0.090 |
Why?
|
Descemet Membrane | 1 | 2009 | 42 | 0.090 |
Why?
|
Conjunctival Neoplasms | 1 | 2010 | 79 | 0.090 |
Why?
|
Lens Implantation, Intraocular | 2 | 2017 | 193 | 0.080 |
Why?
|
Curriculum | 1 | 2021 | 3589 | 0.080 |
Why?
|
Intraocular Pressure | 2 | 2017 | 1274 | 0.080 |
Why?
|
Tonometry, Ocular | 1 | 2009 | 237 | 0.080 |
Why?
|
Eye Diseases | 2 | 2016 | 670 | 0.080 |
Why?
|
Facial Neoplasms | 1 | 2008 | 121 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1581 | 0.080 |
Why?
|
Photophobia | 1 | 2007 | 67 | 0.070 |
Why?
|
Adolescent | 7 | 2021 | 85649 | 0.070 |
Why?
|
Administration, Topical | 1 | 2009 | 688 | 0.070 |
Why?
|
Trypan Blue | 1 | 2006 | 19 | 0.070 |
Why?
|
Pain | 2 | 2023 | 4961 | 0.070 |
Why?
|
Myopia | 1 | 2008 | 254 | 0.070 |
Why?
|
Fluorescein | 1 | 2006 | 169 | 0.070 |
Why?
|
Societies, Medical | 1 | 2017 | 3740 | 0.070 |
Why?
|
Sensation | 2 | 2017 | 337 | 0.060 |
Why?
|
Quality of Life | 6 | 2023 | 12730 | 0.060 |
Why?
|
Child | 6 | 2019 | 77478 | 0.060 |
Why?
|
Indocyanine Green | 1 | 2006 | 238 | 0.060 |
Why?
|
Graft Survival | 2 | 2011 | 3733 | 0.060 |
Why?
|
Chronic Disease | 3 | 2021 | 9144 | 0.060 |
Why?
|
Treatment Outcome | 7 | 2012 | 62966 | 0.060 |
Why?
|
Ultraviolet Rays | 2 | 2019 | 1059 | 0.060 |
Why?
|
Aphakia, Postcataract | 1 | 2003 | 54 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4771 | 0.050 |
Why?
|
Cohort Studies | 2 | 2016 | 40450 | 0.050 |
Why?
|
Sleep | 1 | 2018 | 4604 | 0.050 |
Why?
|
Prosthesis Failure | 2 | 2019 | 1203 | 0.050 |
Why?
|
Ophthalmic Solutions | 1 | 2023 | 313 | 0.050 |
Why?
|
Polymyxins | 1 | 2021 | 22 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2006 | 1099 | 0.050 |
Why?
|
Child, Preschool | 3 | 2019 | 40955 | 0.050 |
Why?
|
Corynebacterium | 1 | 2021 | 47 | 0.050 |
Why?
|
Trimethoprim | 1 | 2021 | 91 | 0.050 |
Why?
|
Immunocompetence | 1 | 2021 | 137 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6171 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19862 | 0.050 |
Why?
|
Time Factors | 2 | 2015 | 40054 | 0.050 |
Why?
|
Ganglia, Spinal | 1 | 2023 | 517 | 0.050 |
Why?
|
Cell Count | 2 | 2016 | 1831 | 0.040 |
Why?
|
Azithromycin | 1 | 2021 | 195 | 0.040 |
Why?
|
Equipment Design | 1 | 2008 | 3582 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12164 | 0.040 |
Why?
|
Lymphoma | 1 | 2008 | 1873 | 0.040 |
Why?
|
United States | 8 | 2021 | 69693 | 0.040 |
Why?
|
Databases, Factual | 3 | 2013 | 7716 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2007 | 2414 | 0.040 |
Why?
|
Corneal Stroma | 1 | 2019 | 170 | 0.040 |
Why?
|
Thermoreceptors | 1 | 2017 | 27 | 0.040 |
Why?
|
Vancomycin | 1 | 2021 | 500 | 0.040 |
Why?
|
Graft Rejection | 1 | 2011 | 4393 | 0.040 |
Why?
|
Jews | 1 | 2019 | 385 | 0.040 |
Why?
|
Metagenomics | 1 | 2021 | 430 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 676 | 0.040 |
Why?
|
Contact Lens Solutions | 1 | 2015 | 1 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2021 | 729 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 1961 | 0.030 |
Why?
|
Photosensitizing Agents | 1 | 2019 | 602 | 0.030 |
Why?
|
Axons | 1 | 2023 | 1681 | 0.030 |
Why?
|
Skull Base | 1 | 2017 | 299 | 0.030 |
Why?
|
Limbus Corneae | 1 | 2016 | 142 | 0.030 |
Why?
|
Fluorophotometry | 1 | 2013 | 39 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2016 | 57683 | 0.030 |
Why?
|
Nociceptors | 1 | 2017 | 432 | 0.030 |
Why?
|
Animals | 2 | 2023 | 168561 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5425 | 0.030 |
Why?
|
Nerve Fibers | 1 | 2017 | 688 | 0.030 |
Why?
|
Epidermis | 1 | 2016 | 527 | 0.030 |
Why?
|
Prospective Studies | 3 | 2012 | 53187 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7153 | 0.030 |
Why?
|
Necrosis | 1 | 2016 | 1643 | 0.030 |
Why?
|
Melanoma | 1 | 2010 | 5462 | 0.020 |
Why?
|
Life Style | 1 | 2023 | 3824 | 0.020 |
Why?
|
Collagen | 1 | 2019 | 2684 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6483 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1436 | 0.020 |
Why?
|
Prognosis | 1 | 2009 | 29010 | 0.020 |
Why?
|
Artificial Organs | 1 | 2010 | 204 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2012 | 2123 | 0.020 |
Why?
|
Infant | 1 | 2008 | 35070 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2016 | 3678 | 0.020 |
Why?
|
Neurons | 1 | 2023 | 9325 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1769 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2009 | 1679 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20928 | 0.010 |
Why?
|
Anterior Chamber | 1 | 2003 | 195 | 0.010 |
Why?
|
Wound Healing | 1 | 2013 | 2781 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2009 | 1188 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4353 | 0.010 |
Why?
|
Iris | 1 | 2003 | 239 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9639 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8333 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 21719 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29717 | 0.010 |
Why?
|
Safety | 1 | 2003 | 1185 | 0.010 |
Why?
|
Suture Techniques | 1 | 2003 | 797 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 5385 | 0.010 |
Why?
|
Inflammation | 1 | 2016 | 10578 | 0.010 |
Why?
|
Boston | 1 | 2009 | 9305 | 0.010 |
Why?
|
Health Care Costs | 1 | 2009 | 3203 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 72145 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 7901 | 0.000 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_